SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-22-003320
Filing Date
2022-02-28
Accepted
2022-02-28 16:01:50
Documents
15
Period of Report
2022-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e2252208k.htm   iXBRL 8-K 30257
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 43889
7 GRAPHIC hgen_logo.jpg GRAPHIC 6614
  Complete submission text file 0001214659-22-003320.txt   307061

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hgen-20220228.xsd EX-101.SCH 3247
4 XBRL DEFINITION FILE hgen-20220228_def.xml EX-101.DEF 26430
5 XBRL LABEL FILE hgen-20220228_lab.xml EX-101.LAB 36200
6 XBRL PRESENTATION FILE hgen-20220228_pre.xml EX-101.PRE 25088
9 EXTRACTED XBRL INSTANCE DOCUMENT e2252208k_htm.xml XML 4821
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 22689216
SIC: 2834 Pharmaceutical Preparations